SCHEMBL4347804

SCHEMBL4347804

CC(O)c1cc(Cl)cc(N(S)C(=O)NCc2ccc(C(F)(F)F)cc2)c1O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 3/20 0.39
TMEM97 Q5BJF2 3/20 0.39
LSS P48449 1/20 0.39
LMNA P02545 1/20 0.39
MTOR P42345 1/20 0.38
PDE2A O00408 1/20 0.38
HDAC3 O15379 1/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC2 Q92769 1/20 0.37
HDAC10 Q969S8 1/20 0.37
HDAC11 Q96DB2 1/20 0.37
HDAC8 Q9BY41 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
PPARA Q07869 3/20 0.37
PPARD Q03181 1/20 0.37
OPRM1 P35372 1/20 0.37
OPRL1 P41146 1/20 0.37
EPHX2 P34913 1/20 0.36
PPARG P37231 1/20 0.36
ALDH1A1 P00352 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4351483 0.85 MTOR (0.42) LSSLMNAMTORHDAC3HDAC1
SCHEMBL4341759 0.85 P2RX1 (0.41) LMNAMTORPDE2AEPHX2SMN1; SMN2
SCHEMBL4354911 0.84 PDE2A (0.40) KCNH2TMEM97LSSMTORPDE2A
SCHEMBL4345514 0.81 MTOR (0.38) KCNH2TMEM97LSSMTORHDAC3
SCHEMBL4348962 0.81 MTOR (0.50) LMNAMTOROPRM1OPRL1EPHX2
SCHEMBL4359745 0.80 TMPRSS4 (0.50) LSSLMNAMTORHDAC3HDAC1
SCHEMBL4355927 0.78 LSS (0.44) KCNH2TMEM97LSSLMNAMTOR
SCHEMBL4347982 0.78 NPC1 (0.41) LMNAPPARGALDH1A1GAAKMT2A
SCHEMBL4354228 0.77 GRIK1 (0.40) ALDH1A1MEN1GAAKMT2ASMN1; SMN2
SCHEMBL4345508 0.76 KMT2A (0.48) LMNAALDH1A1MAPTMEN1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF JERINI AG (DE) 2011-03-17 US claimed
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors JERINI AG (DE) 2007-03-08 US claimed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF NR1I3, NR1D1, NR1D2 KCNH2 1556/4885TMEM97 1427/4885LSS 730/4885
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors NR1I3, NR1D1, NR1D2 KCNH2 2514/4885TMEM97 1815/4885LSS 1073/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.